Skip to main content
Fig. 3 | Cancer Imaging

Fig. 3

From: FDG and FLT-PET for Early measurement of response to 37.5 mg daily sunitinib therapy in metastatic renal cell carcinoma

Fig. 3

FLT-PET images illustrating a proliferative response to 37.5 mg daily sunitinib treatment. Single slice coronal inverted grayscale (a, b) and 21-step color (c, d) FLT-PET images from the same patient as in Fig. 1 (ID#6) showing a proliferative response to lower-dose sunitinib in a right upper lobe lung lesion (circles). a, c: Baseline images prior to initiation of therapy with sunitinib. b, d: Follow-up images obtained after 28 days of treatment with lower-dose sunitinib. Circles mark the location of the tumor to distinguish it from the normal skeletal and hepatic uptake

Back to article page